申请人:Bilodeau T. Mark
公开号:US20070254901A1
公开(公告)日:2007-11-01
The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
本发明涉及含有取代的5-脱氨嘌呤基团的化合物,该化合物抑制Akt蛋白激酶的活性。该发明还涉及含有本发明化合物的化疗组合物以及治疗癌症的方法,包括给予本发明化合物的治疗方法。